Should the Aminoglycoside ß-Lactam Combination Be Abandoned in All Severely Ill Patients With Presumed Gram-Negative Infection?

Lipcsey, Miklos; Castegren, Markus; Furebring, Mia; Sjölin, Jan

Lipcsey, Miklos; Castegren, Markus; Furebring, Mia; Sjölin, Jan.

Afiliação

Lipcsey M; Hedenstierna Laboratory, Anaesthesiology and Intensive Care, Department of Surgical Sciences, Uppsala University, Sweden.
Castegren M; Intensive Care and Surgical Services, Department of Anaesthesia, Karolinska University Hospital, Sweden.
Furebring M; Hedenstierna Laboratory, Anaesthesiology and Intensive Care, Department of Surgical Sciences, Uppsala University, Sweden.
Sjölin J; Section of Infectious Diseases, Department of Medical Sciences, Uppsala University, Sweden.

Clin Infect Dis ; 66(3): 480-482, 2018 01 18.

Article em En | MEDLINE | ID: mdl-29020234

Assuntos

Gentamicinas; Choque Séptico; Aminoglicosídeos; Antibacterianos; Estudos de Coortes; Humanos; Estudos Prospectivos; beta-Lactamas

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Choque Séptico / Gentamicinas Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Choque Séptico / Gentamicinas Idioma: En Ano de publicação: 2018 Tipo de documento: Article